Market Closed -
Other stock markets
|
After market 07:59:30 pm | |||
42.39 USD | +10.10% | 43.56 | +2.75% |
Jan. 21 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
Jan. 21 | Top Midday Gainers | MT |
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
Return on Assets | -19.21 | -10.69 | 51.93 | 23.3 | -11.97 | |||
Return on Total Capital | -23.73 | -23.21 | 93.06 | 33.28 | -14.96 | |||
Return On Equity % | -38 | -39.99 | 146.08 | 50.27 | -28.59 | |||
Return on Common Equity | -38 | -39.99 | 146.08 | 50.27 | -28.59 | |||
Margin Analysis | ||||||||
Gross Profit Margin % | -724.31 | -71.56 | 75.05 | 54.78 | -39.28 | |||
SG&A Margin | 182.07 | 23.43 | 3.07 | 5.88 | 22.62 | |||
EBITDA Margin % | -854.85 | -91.1 | 73.24 | 50.71 | -52.83 | |||
EBITA Margin % | -906.38 | -94.99 | 71.98 | 48.9 | -61.9 | |||
EBIT Margin % | -906.38 | -94.99 | 71.98 | 48.9 | -61.9 | |||
Income From Continuing Operations Margin % | -853.73 | -92.99 | 66.06 | 43.41 | -68.84 | |||
Net Income Margin % | -853.73 | -92.99 | 66.06 | 43.41 | -68.84 | |||
Net Avail. For Common Margin % | -853.73 | -92.99 | 66.06 | 43.41 | -68.84 | |||
Normalized Net Income Margin | -534.31 | -58 | 44.95 | 31.13 | -35.32 | |||
Levered Free Cash Flow Margin | -551.6 | 272.65 | 50.31 | 19.04 | -34.8 | |||
Unlevered Free Cash Flow Margin | -544.74 | 273.42 | 50.37 | 19.14 | -34.45 | |||
Asset Turnover | ||||||||
Asset Turnover | 0.03 | 0.18 | 1.15 | 0.76 | 0.31 | |||
Fixed Assets Turnover | 0.24 | 2.38 | 20.87 | 10.94 | 2.86 | |||
Receivables Turnover (Average Receivables) | 6.71 | 1.15 | 8.09 | 8.45 | 5.86 | |||
Inventory Turnover (Average Inventory) | - | - | 6.19 | 6.02 | 13.27 | |||
Short Term Liquidity | ||||||||
Current Ratio | 7.89 | 1.43 | 1.76 | 2.73 | 3.42 | |||
Quick Ratio | 7.82 | 1.37 | 1.54 | 2.34 | 3.21 | |||
Operating Cash Flow to Current Liabilities | -3.21 | 0.46 | 1.49 | 1.01 | -1.03 | |||
Days Sales Outstanding (Average Receivables) | 54.42 | 317.97 | 45.11 | 43.2 | 62.29 | |||
Days Outstanding Inventory (Average Inventory) | - | - | 58.93 | 60.67 | 27.51 | |||
Average Days Payable Outstanding | 14.08 | - | 9.73 | 17.67 | 21.27 | |||
Cash Conversion Cycle (Average Days) | - | - | 94.32 | 86.21 | 68.54 | |||
Long Term Solvency | ||||||||
Total Debt/Equity | 11.57 | 9.28 | 6.48 | 6.28 | 8.97 | |||
Total Debt / Total Capital | 10.37 | 8.49 | 6.08 | 5.9 | 8.23 | |||
LT Debt/Equity | 11.27 | 8.09 | 4.98 | 5.25 | 8.79 | |||
Long-Term Debt / Total Capital | 10.1 | 7.41 | 4.68 | 4.94 | 8.07 | |||
Total Liabilities / Total Assets | 26.09 | 65.09 | 42.66 | 26.05 | 24.81 | |||
EBIT / Interest Expense | -82.53 | -77.19 | 738.67 | 324.83 | -111.55 | |||
EBITDA / Interest Expense | -74.6 | -70.44 | 761.17 | 344.17 | -89.87 | |||
(EBITDA - Capex) / Interest Expense | -79.38 | -77.27 | 745.39 | 330.38 | -108.47 | |||
Total Debt / EBITDA | -0.28 | -0.34 | 0.07 | 0.12 | -0.36 | |||
Net Debt / EBITDA | 1.96 | 6.28 | -1.22 | -1.71 | 3.53 | |||
Total Debt / (EBITDA - Capex) | -0.26 | -0.31 | 0.07 | 0.13 | -0.3 | |||
Net Debt / (EBITDA - Capex) | 1.84 | 5.72 | -1.24 | -1.78 | 2.92 | |||
Growth Over Prior Year | ||||||||
Total Revenues, 1 Yr. Growth % | -55.42 | 1.23K | 2.2K | 4.29 | -64.45 | |||
Gross Profit, 1 Yr. Growth % | 36.7 | 31.82 | -2.51K | -23.88 | -125.49 | |||
EBITDA, 1 Yr. Growth % | 32.52 | 42.2 | -1.95K | -27.79 | -137.04 | |||
EBITA, 1 Yr. Growth % | 32.05 | 39.84 | -1.84K | -29.15 | -145 | |||
EBIT, 1 Yr. Growth % | 32.05 | 39.84 | -1.84K | -29.15 | -145 | |||
Earnings From Cont. Operations, 1 Yr. Growth % | 33.6 | 45.34 | -1.73K | -31.47 | -156.37 | |||
Net Income, 1 Yr. Growth % | 33.6 | 45.34 | -1.73K | -31.47 | -156.37 | |||
Normalized Net Income, 1 Yr. Growth % | 31.8 | 44.85 | -1.88K | -27.77 | -140.33 | |||
Diluted EPS Before Extra, 1 Yr. Growth % | -68.64 | 26.08 | -1.54K | -28.88 | -161.33 | |||
Accounts Receivable, 1 Yr. Growth % | -57.34 | 25.8K | 128.25 | -56.38 | -35.6 | |||
Inventory, 1 Yr. Growth % | - | - | 2.97K | -32.41 | -76.88 | |||
Net Property, Plant and Equip., 1 Yr. Growth % | 35.82 | 34.45 | 257.36 | 54.66 | 24.26 | |||
Total Assets, 1 Yr. Growth % | -19 | 361.6 | 236.23 | 4.82 | -28.74 | |||
Tangible Book Value, 1 Yr. Growth % | -23.23 | 118.02 | 452.32 | 35.19 | -28.06 | |||
Common Equity, 1 Yr. Growth % | -23.23 | 118.02 | 452.32 | 35.19 | -27.55 | |||
Cash From Operations, 1 Yr. Growth % | 38.72 | -541.64 | 571.93 | -63.43 | -162.6 | |||
Capital Expenditures, 1 Yr. Growth % | -70.17 | 113.75 | 317.65 | 40.84 | 76.75 | |||
Levered Free Cash Flow, 1 Yr. Growth % | 32 |